This content is machine translated Case series Chronic prurigo in atopic patients: successful treatment with dupilumab. A case series of patients with prurigo was published in the journal Acta Dermato Venerologica. After multiple unsuccessful previous therapies, the use of dupilumab resulted in a significant improvement in…
View Post 3 min This content is machine translated Atopic dermatitis Dupilumab not only reduces primary symptoms Comorbid psychological symptoms are common in atopic dermatitis and can have serious consequences. The IgG4 monoclonal antibody dupilumab led to significant symptom reduction in subpopulations of this patient population, resulting…
View Post 9 min This content is machine translated Therapy of plaque psoriasis Antipsoriatics – from skin to luxury problems? In an interview with DERMATOLOGIE PRAXIS, Dr. med. Simon Müller, senior physician in dermatology at the University Hospital Basel, talks about the topic “Therapy of plaque psoriasis”. In doing so,…
View Post 3 min This content is machine translated Psoriasis Update Systemic therapy is indicated for moderate to severe disease PD Dr. med. Dr. sc. Nat. Alexander Navarini, Department of Dermatology at the University Hospital Zurich, held a workshop on psoriasis at Medidays. Moderate to severe psoriasis can be very…
View Post 2 min This content is machine translated Treat psoriasis in practice With plaster against psoriasis plaques Topical steroids are the drugs of choice for milder forms of psoriasis. In addition to conventional creams, patches containing active ingredients are also available for treatment. An important advantage of…
View Post 5 min This content is machine translated Open questions in psoriasis What does the consensus say? The therapeutic goal in moderate to severe plaque psoriasis is to relieve patients of their skin symptoms as much as possible (PASI ≥75%). If this does not succeed within certain…
View Post 7 min This content is machine translated Current psoriasis therapy Comorbidities require careful drug selection Today, biologicals are part of the standard therapy for psoriasis. Pharmaceutical companies are conducting intensive research into new drugs. Experts believe that new biologicals with a similar mechanism of action…
